Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Van Duinkerken, Eelco ^a   IJzerman, Richard G ^a   van der Zijl, Nynke J ^a   Barkhof, Frederik ^a   Pouwels, Petra J W ^a   Schoonheim, Menno M ^a   Moll, Annette C ^a   Boerop, Jeannette ^a   Wessels, Alette M ^a,b   Klein, Martin ^a   Snoek, Frank J ^a   Diamant, Michaela ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Cognition; Microangiopathy; Neuroimaging; Subclinical macroangiopathy; Type 1 diabetes

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTICLE; ASYMPTOMATIC DISEASE; ATTENTION; B SCAN; BRAIN FUNCTION; CAROTID ARTERY DISEASE; COGNITION; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NEUROPSYCHOLOGICAL TEST; PROLIFERATIVE RETINOPATHY; STATISTICAL SIGNIFICANCE; SUBCLINICAL MACROANGIOPATHY; VASCULAR DISEASE; WHITE MATTER;

ADOLESCENT; ADULT; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CELL PROLIFERATION; CEREBROVASCULAR CIRCULATION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84899567945     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-58     Document Type: Article

References (27)

1. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005, 28:726-735. 10.2337/diacare.28.3.726, 15735218.
2. van Duinkerken E, Klein M, Schoonenboom NS, Hoogma RP, Moll AC, Snoek FJ, Stam CJ, Diamant M. Functional brain connectivity and neurocognitive functioning in patients with longstanding type 1 diabetes mellitus with and without microvascular complications: a magnetoencephalography study. Diabetes 2009, 58:2335-2343. 10.2337/db09-0425, 2750229, 19584309.
3. Van Duinkerken E, Schoonheim MM, IJzerman RG, Klein M, Ryan CM, Moll AC, Snoek FJ, Barkhof F, Diamant M, Pouwels PJ. Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions. Diabetologia 2012, 55:1218-1220. 10.1007/s00125-012-2488-2, 3296003, 22327286.
4. van Duinkerken E, Schoonheim MM, Sanz-Arigita EJ, IJzerman RG, Moll AC, Snoek FJ, Ryan CM, Klein M, Diamant M, Barkhof F. Resting-state brain networks in type 1 diabetes patients with and without microangiopathy and their relation with cognitive functions and disease variables. Diabetes 2012, 61:1814-1821. 10.2337/db11-1358, 3379683, 22438575.
5. Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Musen G, Dahms W. Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia 2011, 54:245-255. 10.1007/s00125-010-1883-9, 20803190.
6. Wessels AM, Scheltens P, Barkhof F, Heine RJ. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur J Pharmacol 2008, 585:88-96. 10.1016/j.ejphar.2007.11.080, 18396273.
7. Patton N, Aslam T, MacGillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005, 206:319-348. 10.1111/j.1469-7580.2005.00395.x, 1571489, 15817102.
8. Głowińska-Olszewska B, Urban M, Urban B, Tołwińska J, Szadkowska A. The association of early atherosclerosis and retinopathy in adolescents with type 1 diabetes: preliminary report. Acta Diabetol 2007, 44:131-137. 10.1007/s00592-007-0253-7, 17721751.
9. Frost D, Beischer W. Determinants of carotid artery wall thickening in young patients with Type 1 diabetes mellitus. Diabet Med 1998, 15:851-857. 10.1002/(SICI)1096-9136(199810)15:10<851::AID-DIA660>3.0.CO;2-9, 9796886.
10. Nomura K, Hamamoto Y, Takahara S, Kikuchi O, Honjo S, Ikeda H, Wada Y, Nabe K, Okumra R, Koshiyama H. Relationship between CarotidIntima-media thickness and silent cerebral infarction in Japanese subjects with type 2 diabetes. Diabetes Care 2010, 33:168-170. 10.2337/dc09-0453, 2797965, 19808915.
11. Romero JR, Beiser A, Seshadri S, Benjamin EJ, Polak JF, Vasan RS, Au R, DeCarli C, Wolf PA. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke 2009, 40:1590-1596. 10.1161/STROKEAHA.108.535245, 2705324, 19265054.
12. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjølie AK. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 1995, 38:437-444. 10.1007/BF00410281, 7796984.
13. Polak JF, Backlund J-YC, Cleary PA, Harrington AP, O'Leary DH, Lachin JM, Nathan DM, for the DERG Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 2011, 60:607-613. 10.2337/db10-0296, 3028362, 21270271, for the DERG.
14. Dogansen S, Helvaci A, Adas M, Onal S. The relationship between early atherosclerosis and endothelial dysfunction in type 1 diabetic patients as evidenced by measurement of carotid intima-media thickness and soluble CD146 levels: a cross sectional study. Cardiovasc Diabetol 2013, 12:153. 10.1186/1475-2840-12-153, 24139427.
15. Tu T, Gao Q, Luo Y, Chen J, Lu D, Feng J, Yang D, Song L, Yan X. CD146 Deletion in the nervous system impairs appetite. Locomotor activity and spatial learning in mice. PLoS ONE 2013, 8:e74124. 10.1371/journal.pone.0074124, 3769362, 24040184.
16. Touboul P-J, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif J-C, Taylor A, Vicaut E, Woo KS. An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European stroke conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012, 34:290-296. 10.1159/000343145, 3760791, 23128470.
17. Gunning-Dixon FM, Brickman AM, Cheng JC, Alexopoulos GS. Aging of cerebral white matter: a review of MRI findings. Int J Geriatr Psychiatry 2009, 24:109-117. 10.1002/gps.2087, 2631089, 18637641.
18. Bressler SL. Understanding cognition through large-scale cortical networks. Curr Dir Psychol Sci 2002, 11:58-61.
19. Woerdeman J, van Duinkerken E, Wattjes MP, Barkhof F, Snoek FJ, Moll AC, Klein M, de Boer MP, IJzerman RG, Serné EH, Diamant M. Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy. Diabetes Care 2013, Epub ahead of print: doi:10.2337/dc2313-1586.
20. van Golen LW, Huisman MC, Ijzerman RG, Hoetjes NJ, Schwarte LA, Lammertsma AA, Diamant M. Cerebral blood flow and glucose metabolism measured with positron emission tomography Are decreased in human type 1 diabetes. Diabetes 2013, 62:2898-2904. 10.2337/db12-1159, 23530004.
21. van Elderen S, Brandts A, Westenberg J, van der Grond J, Tamsma J, van Buchem M, Romijn J, Kroft L, Smit J, de Roos A. Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging. Eur Radiol 2010, 20:1132-1138. 10.1007/s00330-009-1655-4, 2850521, 19915847.
22. van Elderen SGC, Brandts A, van der Grond J, Westenberg JJM, Kroft LJM, van Buchem MA, Smit JWA, de Roos A. Cerebral perfusion and aortic stiffness Are independent predictors of white matter brain atrophy in type 1 diabetic patients assessed with magnetic resonance imaging. Diabetes Care 2011, 34:459-463. 10.2337/dc10-1446, 3024367, 21216862.
23. Laugesen E, Hoyem P, Stausbol-Gron B, Mikkelsen A, Thrysoe S, Erlandsen M, Christiansen JS, Knudsen ST, Hansen KW, Kim WY, Hansen TK, Poulsen PL. Carotid-femoral pulse wave velocity is associated with cerebral white matter lesions in type 2 diabetes. Diabetes Care 2013, 36:722-728. 10.2337/dc12-0942, 3579355, 23129135.
24. Ryan CM. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes 2006, 7:289-297. 10.1111/j.1399-5448.2006.00206.x, 17054452.
25. van den Oord SCH, Sijbrands EJG, ten Kate GL, van Klaveren D, van Domburg RT, van der Steen AFW, Schinkel AFL. Carotid intima-media thickness for cardiovascular risk assessment: systematic review and meta-analysis. Atherosclerosis 2013, 228:1-11. 10.1016/j.atherosclerosis.2013.01.025, 23395523.
26. Lorenz MW, Polak JF, Kavousi M, Mathiesen EB, Vözke H, Tuomainen T-P, Sander D, Plichart M, Catapano AL, Robertson CM, Kiechl S, Rundek T, Desvarieux M, Lind L, Schmid C, DasMahapatra P, Gao L, Ziegelbauer K, Bots ML, Thompson SG. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 2012, 379:2053-2062. 10.1016/S0140-6736(12)60441-3, 3918517, 22541275.
27. Peters SAE, den Ruijter HM, Bots ML, Moons KGM. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012, 98:177-184. 10.1136/heartjnl-2011-300747, 22095617.